KPV
Anti-Inflammatory Tripeptide
A tripeptide derived from alpha-MSH studied for its anti-inflammatory and gut-protective properties.
Overview
KPV is a C-terminal tripeptide (Lys-Pro-Val) derived from alpha-melanocyte-stimulating hormone (α-MSH). Research has investigated its anti-inflammatory properties and its potential role in gut health and inflammatory bowel disease models.
Research Information
Research on KPV has demonstrated its ability to reduce inflammatory cytokine production and modulate NF-κB signaling. Studies have investigated its effects on intestinal inflammation in animal models of colitis. Research has also explored its potential in wound healing and skin inflammation.
Research Dosage Reference
Research protocols use oral or subcutaneous administration. Standard vials contain 5mg lyophilized powder. All dosing information is for research reference only.
Related Research
Disclaimer: All information provided is for educational and research purposes only. This is not medical advice. These compounds are not approved for human use. Always consult with qualified professionals before conducting research.